Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: December 3, 2024
Reporting Period: Event date December 3, 2024
Business Context: The Company is an emerging growth company incorporated in Delaware, trading on The Nasdaq Stock Market LLC. This filing serves as a Regulation FD disclosure to furnish a presentation regarding the Company's business and operations made available on the filing date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the availability of a presentation rather than a financial statement containing quantitative data.
Material Changes
No material changes to financial results or operations are detailed within the text of this filing. The primary event is the public release of a business presentation.
Guidance, Outlook, and Risks
Management Commentary: The Company furnished a presentation (Exhibit 99.1) relating to its business and operations, accessible via the Investors section of its website (www.ibs.inc).
Legal Status of Information: The information contained in Item 7.01 and Exhibit 99.1 is being "furnished" and is not deemed "filed" under the Securities Exchange Act of 1934. It shall not be incorporated by reference into any other filing unless specifically identified as such.
Risks and Contingencies: No specific risks or contingencies are enumerated in the text of this 8-K filing.
Investor Verification Checklist
- Verify the content of the presentation (Exhibit 99.1) on the Company's investor website to obtain actual business metrics and outlook.
- Confirm the Company's status as an emerging growth company and its implications for financial reporting standards.
- Note that the presentation materials are not legally "filed" with the SEC and may not be incorporated by reference in future litigation or filings without explicit identification.
- Review the Company's most recent 10-K or 10-Q for audited financial data, as this 8-K contains no numerical financial results.